Leadership changes, September 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,052
Appointments
619
Departures
64
Browse by role
September 2026
Get new CFO appointments the day the filing lands.
Filters
1,052 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Petros Pharmaceuticals, Inc. | Fady Boctor | President and Chief Commercial OfficerPresident | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 30, 2026 | SOCIETY PASS INCORPORATED. | Jeremy Rosenthal | member of the Board of Directorsmember of the Board of Directors | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 30, 2026 | SOCIETY PASS INCORPORATED. | Michael Dunn | member of the Boardmember of the Board | Departed | Sep 11, 2026 | SEC 8-K |
| Sep 30, 2026 | SOCIETY PASS INCORPORATED. | Travis Washko | member of the Boardmember of the Board | Departed | Sep 11, 2026 | SEC 8-K |
| Sep 30, 2026 | SOCIETY PASS INCORPORATED. | Ray Liang | Chief Executive OfficerCEO | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 30, 2026 | SOCIETY PASS INCORPORATED. | Tan Yee Siong | Chief Financial OfficerCFO | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 30, 2026 | Ultra Clean Holdings, Inc. | Alexander Davern | member of the Boardmember of the Board | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 30, 2026 | Vivakor, Inc. | Leslie D. Patterson | Executive Vice President and Chief Operating OfficerCOO | Departed | Sep 24, 2026 | SEC 8-K |
| Sep 29, 2026 | ACUITY INC. (DE) | Nick Tzitzon | DirectorDirector | Appointed | Sep 24, 2026 | SEC 8-K |
| Sep 29, 2026 | Altimmune, Inc. | Richard Menziuso | Vice President, Global Controller and Principal Accounting OfficerVice President, Global Controller and Principal Accounting Officer | Appointed | Sep 29, 2026 | SEC 8-K |
| Sep 29, 2026 | Aquestive Therapeutics, Inc. | Richard J. Daly | directordirector | Appointed | Oct 14, 2026 | SEC 8-K |
| Sep 29, 2026 | Arrive AI Inc. | Mark Hamm | Chief Operating OfficerCOO | Departed | Oct 2, 2026 | SEC 8-K |
| Sep 29, 2026 | Aterian, Inc. | Avraham Ben-Tzvi | member of the Boardmember of the Board | Departed | Sep 25, 2026 | SEC 8-K |
| Sep 29, 2026 | Aterian, Inc. | William H. Crampton | member of the Boardmember of the Board | Appointed | Sep 25, 2026 | SEC 8-K |
| Sep 29, 2026 | AVAX ONE TECHNOLOGY LTD. | Stephanie Brady | Chief Accounting OfficerChief Accounting Officer | Appointed | Aug 19, 2026 | SEC 8-K |
| Sep 29, 2026 | BioAtla, Inc. | Eric Sievers | Chief Medical OfficerCMO | Departed | Sep 25, 2026 | SEC 8-K |
| Sep 29, 2026 | CareCloud, Inc. | Bonnie Boyer | Chief Financial OfficerCFO | Appointed | Oct 1, 2026 | SEC 8-K |
| Sep 29, 2026 | CareCloud, Inc. | Norman Roth | Advisor to the Chief Executive OfficerCEO | Role change | Oct 1, 2026 | SEC 8-K |
| Sep 29, 2026 | Celularity Inc | Naveen Jain | member of the Boardmember of the Board | Appointed | n/a | SEC 8-K |
| Sep 29, 2026 | Celularity Inc | Diane Parks | member of the Boardmember of the Board | Departed | n/a | SEC 8-K |
- Petros Pharmaceuticals, Inc.Departed
Fady Boctor President
Filed Sep 30, 2026Effective Sep 30, 2026SEC 8-K
- SOCIETY PASS INCORPORATED.Departed
Jeremy Rosenthal member of the Board of Directors
Filed Sep 30, 2026Effective Sep 8, 2026SEC 8-K
- SOCIETY PASS INCORPORATED.Departed
Michael Dunn member of the Board
Filed Sep 30, 2026Effective Sep 11, 2026SEC 8-K
- SOCIETY PASS INCORPORATED.Departed
Travis Washko member of the Board
Filed Sep 30, 2026Effective Sep 11, 2026SEC 8-K
- SOCIETY PASS INCORPORATED.Departed
Ray Liang CEO
Filed Sep 30, 2026Effective Sep 30, 2026SEC 8-K
- SOCIETY PASS INCORPORATED.Departed
Tan Yee Siong CFO
Filed Sep 30, 2026Effective Sep 30, 2026SEC 8-K
- Ultra Clean Holdings, Inc.Appointed
Alexander Davern member of the Board
Filed Sep 30, 2026Effective Sep 28, 2026SEC 8-K
- Vivakor, Inc.Departed
Leslie D. Patterson COO
Filed Sep 30, 2026Effective Sep 24, 2026SEC 8-K
- ACUITY INC. (DE)Appointed
Nick Tzitzon Director
Filed Sep 29, 2026Effective Sep 24, 2026SEC 8-K
- Altimmune, Inc.Appointed
Richard Menziuso Vice President, Global Controller and Principal Accounting Officer
Filed Sep 29, 2026Effective Sep 29, 2026SEC 8-K
- Aquestive Therapeutics, Inc.Appointed
Richard J. Daly director
Filed Sep 29, 2026Effective Oct 14, 2026SEC 8-K
- Arrive AI Inc.Departed
Mark Hamm COO
Filed Sep 29, 2026Effective Oct 2, 2026SEC 8-K
- Aterian, Inc.Departed
Avraham Ben-Tzvi member of the Board
Filed Sep 29, 2026Effective Sep 25, 2026SEC 8-K
- Aterian, Inc.Appointed
William H. Crampton member of the Board
Filed Sep 29, 2026Effective Sep 25, 2026SEC 8-K
- AVAX ONE TECHNOLOGY LTD.Appointed
Stephanie Brady Chief Accounting Officer
Filed Sep 29, 2026Effective Aug 19, 2026SEC 8-K
- BioAtla, Inc.Departed
Eric Sievers CMO
Filed Sep 29, 2026Effective Sep 25, 2026SEC 8-K
- CareCloud, Inc.Appointed
Bonnie Boyer CFO
Filed Sep 29, 2026Effective Oct 1, 2026SEC 8-K
- CareCloud, Inc.Role change
Norman Roth CEO
Filed Sep 29, 2026Effective Oct 1, 2026SEC 8-K
- Celularity IncAppointed
Naveen Jain member of the Board
Filed Sep 29, 2026SEC 8-K
- Celularity IncDeparted
Diane Parks member of the Board
Filed Sep 29, 2026SEC 8-K